Go Pro

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$17.57 +0.43 (+2.51%)
As of 03:15 PM Eastern

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
34
Total
Institutional Inflows
(last 12 months)
$144.90M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$16.65M
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2026Bank of America Corp DE25,821$465K0.0%N/A0.070%
8/14/2026ADAR1 Capital Management LLC18,275$329K0.0%N/A0.049%
8/14/2026Legal & General Group Plc2,097$38K0.0%N/A0.006%
8/14/2026The Manufacturers Life Insurance Company 17,755$320K0.0%N/A0.048%
8/7/2026 BlackRock Inc.1,271,762$22.89M0.0%N/A4.615%
8/7/2026 Persistent Asset Partners Ltd10,968$197K0.1%N/A0.040%
8/6/2026 Bank of New York Mellon Corp45,778$824K0.0%N/A0.166%
5/29/2026Perceptive Advisors LLC206,942$3.80M0.1%-54.4%0.751%
5/19/2026Bank of America Corp DE29,277$538K0.0%+425.3%0.106%
5/18/2026ADAR1 Capital Management LLC50,273$924K0.1%-91.7%0.182%
5/18/2026Exome Asset Management LLC153,191$2.81M1.5%N/A0.556%
5/15/2026 OMERS ADMINISTRATION Corp17,800$327K0.0%+53.4%0.065%
5/14/2026 Renaissance Technologies LLC24,262$446K0.0%-48.0%0.088%
5/6/2026 Jennison Associates LLC152,974$2.81M0.0%N/A0.555%
4/21/2026 Cannon Global Investment Management LLC10,200$187K0.4%N/A0.073%
2/18/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.362%
2/18/2026Vestal Point Capital LP1,500,000$17.79M0.6%N/A10.797%
2/18/2026Tang Capital Management LLC872,398$10.35M0.5%+28.3%6.279%
2/18/2026 Quadrature Capital Ltd13,246$157K0.0%N/A0.095%
2/18/2026RTW Investments LP372,856$4.42M0.0%N/A2.684%
2/18/2026Opaleye Management Inc.1,178,300$13.98M1.8%N/A8.483%
2/18/2026Millennium Management LLC61,882$734K0.0%N/A0.446%
2/18/2026Moore Capital Management LP25,000$296K0.0%N/A0.180%
2/18/2026Balyasny Asset Management L.P.111,715$1.33M0.0%N/A0.804%
2/18/2026BVF Inc. IL2,748,763$32.60M1.1%+98.1%19.790%
2/17/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.363%
2/17/2026Burkehill Global Management LP74,000$844K0.1%N/A0.533%
2/17/2026Heights Capital Management Inc.264,000$3.13M1.1%N/A1.901%
2/17/2026Price T Rowe Associates Inc. MD338,125$4.01M0.0%-11.9%2.434%
2/17/2026Fcpm Iii Services B.V.1,677,852$19.90M2.6%N/A12.080%
2/16/2026 OMERS ADMINISTRATION Corp11,600$138K0.0%N/A0.084%
2/16/2026NEXTBio Capital Management LP372,856$4.42M2.6%N/A2.684%
2/13/2026 Marshall Wace LLP21,826$259K0.0%-50.0%0.157%
2/13/2026Alyeska Investment Group L.P.264,000$3.11M0.0%N/A1.901%
2/13/2026 State Street Corp26,217$311K0.0%+40.8%0.189%
2/12/2026Jane Street Group LLC22,965$272K0.0%N/A0.165%
2/12/2026HRT Financial LP13,083$155K0.0%N/A0.094%
2/12/2026 Renaissance Technologies LLC46,700$554K0.0%+73.6%0.336%
2/10/2026Goldman Sachs Group Inc.25,245$299K0.0%-31.7%0.182%
2/9/2026 Geode Capital Management LLC91,079$1.08M0.0%+31.7%0.656%
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
2/9/2026Jefferies Financial Group Inc.64,244$762K0.0%-37.5%0.462%
11/17/2025Citadel Advisors LLC25,593$304K0.0%N/A0.184%
11/17/2025Commodore Capital LP450,829$5.36M0.3%-0.6%3.245%
11/17/2025Bank of America Corp DE3,863$46K0.0%-58.2%0.028%
11/14/2025Two Sigma Investments LP28,318$337K0.0%N/A0.204%
11/13/2025Jefferies Financial Group Inc.102,714$1.22M0.0%+279.1%0.739%
11/7/2025Vanguard Group Inc.657,900$7.82M0.0%N/A3.365%
8/15/2025 Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
8/15/2025Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025 Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%


CBIO Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($32.60M), BlackRock Inc. ($22.89M), Fcpm Iii Services B.V. ($19.90M), Vestal Point Capital LP ($17.79M), Opaleye Management Inc. ($13.98M), Tang Capital Management LLC ($10.35M), and Vanguard Group Inc. ($7.82M).Learn more on Crescent Biopharma's institutional investors.

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Of the 41 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.75M), Fcpm Iii Services B.V. ($1.68M), Vestal Point Capital LP ($1.50M), BlackRock Inc. ($1.27M), ADAR1 Capital Management LLC ($1.23M), Opaleye Management Inc. ($1.18M), and Vanguard Group Inc. ($657.90K).

Institutional investors have bought a total of 11,304,328 shares in the last 24 months. This purchase volume represents approximately $144.90M in transactions.

Of the 9 institutional investors that sold Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ADAR1 Capital Management LLC ($555.73K), Perceptive Advisors LLC ($246.74K), Price T Rowe Associates Inc. MD ($45.47K), Jefferies Financial Group Inc. ($38.47K), Renaissance Technologies LLC ($22.44K), Marshall Wace LLP ($21.87K), and Goldman Sachs Group Inc. ($11.73K).

Institutional investors have sold a total of 950,672 shares in the last 24 months. This volume of shares sold represents approximately $16.65M in transactions.



Institutional ownership data for NASDAQ:CBIO is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/17/2026. New 13F filings are added each quarter as they're published.
From Our Partners